The role of fibrocytes in sickle cell lung disease

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Field, Joshua J ^b   Burdick, Marie D ^a   DeBaun, Michael R ^c   Strieter, Brett A ^a   Liu, Ling ^a   Mehrad, Borna ^a   Rose, C Edward ^a   Linden, Joel ^d   Strieter, Robert M ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b BLOOD RESEARCH INSTITUTE   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; SMAD2 PROTEIN; SMAD3 PROTEIN; STROMAL CELL DERIVED FACTOR 1; CHEMOKINE RECEPTOR; COLLAGEN; CXCL12 PROTEIN, HUMAN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; BONE MARROW CELL; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL COUNT; CELL MIGRATION; CELL TRANSPORT; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; FIBROCYTE; HUMAN; HUMAN CELL; HYPOXIA; LUNG COMPLIANCE; LUNG DISEASE; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MOUSE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PHENOTYPE; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REOXYGENATION; SICKLE CELL ANEMIA; SICKLE CELL BETA THALASSEMIA; SIGNAL TRANSDUCTION; ANIMAL; CELL MOTION; CLINICAL TRIAL; INTERSTITIAL LUNG DISEASE; LUNG FIBROSIS; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALIA;

ADULT; ANEMIA, SICKLE CELL; ANIMALS; CELL MOVEMENT; CHEMOKINE CXCL12; COLLAGEN; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MICE; MIDDLE AGED; PULMONARY FIBROSIS; RECEPTORS, CHEMOKINE;

EID: 84863389833     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033702     Document Type: Article

References (41)

1. Ashley-Koch A, Yang Q, Olney RS, (2000) Sickle hemoglobin (HbS) allele and sickle cell disease: a HuGE review. American Journal of Epidemiology 151: 839-845.
2. Powars D, Weidman JA, Odom-Maryon T, Niland JC, Johnson C, (1988) Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure. Medicine (Baltimore) 67: 66-76.
3. Powars DR, Chan LS, Hiti A, Ramicone E, Johnson C, (2005) Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine (Baltimore) 84: 363-376.
4. Gladwin MT, Vichinsky E, (2008) Pulmonary complications of sickle cell disease. N Engl J Med 359: 2254-2265.
5. Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, et al. (2004) Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 350: 886-895.
6. Klings ES, Wyszynski DF, Nolan VG, Steinberg MH, (2006) Abnormal pulmonary function in adults with sickle cell anemia. Am J Respir Crit Care Med 173: 1264-1269.
7. McMillan TR, Moore BB, Weinberg JB, Vannella KM, Fields WB, et al. (2008) Exacerbation of established pulmonary fibrosis in a murine model by gammaherpesvirus. Am J Respir Crit Care Med 177: 771-780.
8. Strieter RM, (2001) Mechanisms of pulmonary fibrosis: conference summary. Chest 120: 77S-85S.
9. Strieter RM, (2008) What differentiates normal lung repair and fibrosis? Inflammation, resolution of repair, and fibrosis. Proc Am Thorac Soc 5: 305-310.
10. Strieter RM, Gomperts BN, Keane MP, (2007) The role of CXC chemokines in pulmonary fibrosis. J Clin Invest 117: 549-556.
11. Fukuda Y, Ishizaki M, Masuda Y, Kimura G, Kawanami O, et al. (1987) The role of intraalveolar fibrosis in the process of pulmonary structural remodeling in patients with diffuse alveolar damage. Am J Pathol 126: 171-182.
12. Marshall R, Bellingan G, Laurent G, (1998) The acute respiratory distress syndrome: fibrosis in the fast lane. Thorax 53: 815-817.
13. Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, et al. (2004) Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 114: 438-446.
14. Metz CN, (2003) Fibrocytes: a unique cell population implicated in wound healing. Cell Mol Life Sci 60: 1342-1350.
15. Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A, (1994) Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1: 71-81.
16. Keeley EC, Mehrad B, Strieter RM, (2011) The role of fibrocytes in fibrotic diseases of the lungs and heart. Fibrogenesis Tissue Repair 4: 2.
17. Strieter RM, Keeley EC, Hughes MA, Burdick MD, Mehrad B, (2009) The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis. J Leukoc Biol.
18. Keeley EC, Mehrad B, Strieter RM, (2009) Fibrocytes: bringing new insights into mechanisms of inflammation and fibrosis. Int J Biochem Cell Biol 42: 535-542.
19. Gomperts BN, Strieter RM, (2007) Fibrocytes in lung disease. J Leukoc Biol 82: 449-456.
20. Moore BB, Kolodsick JE, Thannickal VJ, Cooke K, Moore TA, et al. (2005) CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol 166: 675-684.
21. van Deventer HW, Wu QP, Bergstralh DT, Davis BK, O'Connor BP, et al. (2008) C-C chemokine receptor 5 on pulmonary fibrocytes facilitates migration and promotes metastasis via matrix metalloproteinase 9. Am J Pathol 173: 253-264.
22. Pilling D, Roife D, Wang M, Ronkainen SD, Crawford JR, et al. (2007) Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P. J Immunol 179: 4035-4044.
23. Mehrad B, Burdick MD, Zisman DA, Keane MP, Belperio JA, et al. (2007) Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. Biochem Biophys Res Commun 353: 104-108.
24. Andersson-Sjoland A, de Alba CG, Nihlberg K, Becerril C, Ramirez R, et al. (2008) Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis. Int J Biochem Cell Biol 40: 2129-2140.
25. Moeller A, Gilpin SE, Ask K, Cox G, Cook D, et al. (2009) Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 179: 588-594.
26. Phillips RJ, Burdick MD, Lutz M, Belperio JA, Keane MP, et al. (2003) The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. Am J Respir Crit Care Med 167: 1676-1686.
27. Blease K, Schuh JM, Jakubzick C, Lukacs NW, Kunkel SL, et al. (2002) Stat6-deficient mice develop airway hyperresponsiveness and peribronchial fibrosis during chronic fungal asthma. Am J Pathol 160: 481-490.
28. Keane MP, Belperio JA, Arenberg DA, Burdick MD, Xu ZJ, et al. (1999) IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis. J Immunol 163: 5686-5692.
29. Hong KM, Belperio JA, Keane MP, Burdick MD, Strieter RM, (2007) Differentiation of human circulating fibrocytes as mediated by transforming growth factor-beta and peroxisome proliferator-activated receptor gamma. J Biol Chem 282: 22910-22920.
30. Mehrad B, Burdick MD, Strieter RM, (2009) Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis. Int J Biochem Cell Biol 41: 1708-1718.
31. Wallace KL, Marshall MA, Ramos SI, Lannigan JA, Field JJ, et al. (2009) NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-gamma and CXCR3 chemokines. Blood 114: 667-676.
32. Phillips RJ, Mestas J, Gharaee-Kermani M, Burdick MD, Sica A, et al. (2005) Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alpha. J Biol Chem 280: 22473-22481.
33. Burdick MD, Murray LA, Keane MP, Xue YY, Zisman DA, et al. (2005) CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling. Am J Respir Crit Care Med 171: 261-268.
34. Maeda A, Hiyama K, Yamakido H, Ishioka S, Yamakido M, (1996) Increased expression of platelet-derived growth factor A and insulin-like growth factor-I in BAL cells during the development of bleomycin-induced pulmonary fibrosis in mice. Chest 109: 780-786.
35. Baran CP, Opalek JM, McMaken S, Newland CA, O'Brien JM Jr, et al. (2007) Important roles for macrophage colony-stimulating factor, CC chemokine ligand 2, and mononuclear phagocytes in the pathogenesis of pulmonary fibrosis. Am J Respir Crit Care Med 176: 78-89.
36. Kaul DK, Hebbel RP, (2000) Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice. J Clin Invest 106: 411-420.
37. Osarogiagbon UR, Choong S, Belcher JD, Vercellotti GM, Paller MS, et al. (2000) Reperfusion injury pathophysiology in sickle transgenic mice. Blood 96: 314-320.
38. De Castro LM, Jonassaint JC, Graham FL, Ashley-Koch A, Telen MJ, (2008) Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes. Am J Hematol 83: 19-25.
39. Ataga KI, Moore CG, Jones S, Olajide O, Strayhorn D, et al. (2006) Pulmonary hypertension in patients with sickle cell disease: a longitudinal study. Br J Haematol 134: 109-115.
40. Anthi A, Machado RF, Jison ML, Taveira-Dasilva AM, Rubin LJ, et al. (2007) Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension. Am J Respir Crit Care Med 175: 1272-1279.
41. Platt OS, Thorington BD, Brambilla DJ, Milner PF, Rosse WF, et al. (1991) Pain in sickle cell disease. Rates and risk factors. N Engl J Med 325: 11-16.